Ignite Creation Date:
2025-12-25 @ 1:12 AM
Ignite Modification Date:
2026-02-24 @ 5:50 AM
Study NCT ID:
NCT02260193
Status:
COMPLETED
Last Update Posted:
2022-07-01
First Post:
2014-09-25
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
16-Week Repeat Oral Dose Study of AKB-6548 for Anemia in Participants With End Stage Renal Disease (ESRD) Requiring Chronic Hemodialysis
Sponsor:
Akebia Therapeutics
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2014-09-10
Start Date Type:
ACTUAL
Primary Completion Date:
2015-07-22
Primary Completion Date Type:
ACTUAL
Completion Date:
2015-07-22
Completion Date Type:
ACTUAL
First Submit Date:
2014-09-25
First Submit QC Date:
None
Study First Post Date:
2014-10-09
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2022-04-22
Results First Submit QC Date:
None
Results First Post Date:
2022-07-01
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
2015-11-17
Disp First Post Date Type:
ESTIMATED
Last Update Submit Date:
2022-06-07
Last Update Post Date:
2022-07-01
Last Update Post Date Type:
ACTUAL